By G HossainPosted on January 6, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo. Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026 Post navigation 2026: Putting the Reindustrialization Mandate Into PracticeRhode Island eyes tax on rich to counter Trump policies